SISCAPA Assay Technologies develops immunoassays for the quantitation of protein biomarkers and targets. Watch the 2 min overview video to learn more!
https://t.co/cwPAHa3ELU
“The biggest takeaway from my @uviccoopcareer with @SISCAPA is an appreciation for the importance & complexity of developing an accurate diagnostic test for any disease. I'll continue my research as a #UVic Honours student with Dr. Cameron this Fall.”
🔬Angela Mitchell (she/her)
"I oversee the dev. of diagnostic tests for UVic-SISCAPA projects. I've known Caroline for about 10 yrs: she's an esteemed scientist & simply an outstanding person. There's no one I'd rather collaborate with."
🔬Matt Pope(he/him), @SISCAPA General Manager https://t.co/B0wwKJxrEU
Congratulations Dr. Cameron! It is a pleasure for SISCAPA Assay Technologies to collaborate with the Cameron Lab on this project.
https://t.co/wGADgmXiGy
This new article, from Ghent University, features the use of SISCAPA technology in the development of a SARS-CoV-2 LC-MS assay!
https://t.co/fS8cOfEE5t
SISCAPA Assay Technologies develops immunoassays for the quantitation of protein biomarkers and targets. Watch the 2 min overview video to learn more!
https://t.co/cwPAHa3ELU
Learn more about how working with @Crucial_Data has allowed @SISCAPA to seamlessly collect data for longitudinal health studies.
https://t.co/XrPCRTzj33
SISCAPA Assay Technologies develops immunoassays for the quantitation of protein biomarkers and targets. Watch the 2 min overview video to learn more!
https://t.co/cwPAH9M3Um
SISCAPA(R) technology radically improves the sensitivity and throughput of mass spectrometry-based protein tests through specific enrichment of selected target peptides from sample digests.
https://t.co/SgW5aDhthg
Did you miss our virtual panel on September 8th where we discussed a new approach for real-time continuous data collection and the future of #decentralizedtrials? Check out the on-demand recording here! https://t.co/X18uoxOgWt
We hope you’ll join us at 1:00 ET on Sept. 8th for a free virtual panel as CDS’ Jeff Rogers explores a new approach for real-world, continuous data collection and how it applies to #decentralizedtrials alongside SISCAPA Assay Technologies and Merck. https://t.co/moLFNvLsGC
Please be sure to join us alongside one of our business partners, @SISCAPA, for a @PharmaVOICE virtual panel on September 8th at 1:00pm ET https://t.co/moLFNvLsGC
SISCAPA Assay Technologies develops immunoassays for the quantitation of protein biomarkers and targets. Watch the 2 min overview video to learn more!
https://t.co/cwPAH9M3Um
@WatersCorp covid kit utilizes the "innovative anti-peptide antibody enrichment sample preparation method and antibodies from #SISCAPA Assay Technologies that improves the performance of mass spectrometry for measurement of pre-selected protein targets."
https://t.co/TERmKnEdZu